Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.
Perrone G, Rigacci L, Urru S, Kovalchuk S, Brugia M, Fabbri A, Iovino L, Puccini B, Cencini E, Orciuolo E, Birtolo S, Melosi A, Santini S, Landini I, Roviello G, Santi R, Macciotta A, Ricceri F, Bosi A, Bocchia M, Petrini M, Mini E, Nobili S. Perrone G, et al. Among authors: landini i. Cancers (Basel). 2023 May 13;15(10):2753. doi: 10.3390/cancers15102753. Cancers (Basel). 2023. PMID: 37345090 Free PMC article.
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma.
Nobili S, Napoli C, Puccini B, Landini I, Perrone G, Brugia M, Benelli G, Doria M, Martelli M, Finolezzi E, Di Rocco A, Del Fava E, Rigacci L, Di Lollo S, Bosi A, Mini E. Nobili S, et al. Among authors: landini i. Leuk Lymphoma. 2014 Sep;55(9):2071-8. doi: 10.3109/10428194.2013.866665. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24289107
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Russo V, Lallo E, Munnia A, Spedicato M, Messerini L, D'Aurizio R, Ceroni EG, Brunelli G, Galvano A, Russo A, Landini I, Nobili S, Ceppi M, Bruzzone M, Cianchi F, Staderini F, Roselli M, Riondino S, Ferroni P, Guadagni F, Mini E, Peluso M. Russo V, et al. Among authors: landini i. Cancers (Basel). 2022 Aug 19;14(16):4012. doi: 10.3390/cancers14164012. Cancers (Basel). 2022. PMID: 36011003 Free PMC article. Review.
Emerging drugs in refractory colorectal cancer.
Nobili S, Galletta A, Brugia M, Tassi R, Petreni P, Landini I, Mini E. Nobili S, et al. Among authors: landini i. Future Med Chem. 2015 Aug;7(12):1491-501. doi: 10.4155/fmc.15.85. Epub 2015 Aug 21. Future Med Chem. 2015. PMID: 26293581 Review.
ERRATUM.
Mini E, Landini I, Lucarini L, Lapucci A, Napoli C, Perrone G, Tassi R, Masini E, Moroni F, Nobili S. Mini E, et al. Among authors: landini i. Oncol Res. 2018 Mar 5;26(2):333-334. doi: 10.3727/096504018X15187172557369. Oncol Res. 2018. PMID: 29514732 Free PMC article.
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Mini E, Lapucci A, Perrone G, D'Aurizio R, Napoli C, Brugia M, Landini I, Tassi R, Picariello L, Simi L, Mancini I, Messerini L, Magi A, Pinzani P, Mazzei T, Tonelli F, Nobili S. Mini E, et al. Among authors: landini i. Int J Cancer. 2019 Nov 1;145(9):2580-2593. doi: 10.1002/ijc.32326. Epub 2019 Jun 3. Int J Cancer. 2019. PMID: 30973654 Free article.
47 results